FLX-787

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameFLX-787
Drug Alias NameFLX-787
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsFasciculationMotor Neuron DiseaseCharcot-Marie-Tooth Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFlex Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFlex Pharma Inc
Active IndicationsN/A
Inactive IndicationsFasciculationMotor Neuron DiseaseCharcot-Marie-Tooth Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A